
Federal Case Reveals Weak Spot in U.S. Disease Lab Oversight
Two NIH researchers face charges for smuggling deactivated mpox samples out of Africa and deceiving authorities—exposing a critical gap in biosafety enforcement. The system relies on scientists to police themselves. When insiders break those rules, regulators lack the resources to catch them. With dangerous pathogens at stake, that vulnerability carries real weight.
Published